Video interview with patient with childhood asthma and ABPA, who showed a marked improvement in her ABPA and asthma when she commenced nebulised Amphotericin B. Her medication was changed from itraconazole at this time to allow for her to try for pregnancy. Two types of nebuliser – VentStream and the Pari LC system are discussed in the interview. Her condition is still stable using inhaled amphotericin B. We thank the patient for kindly providing this interview
Share this post
Latest News posts
Aspergillosis Weekly Support Meeting
February 15, 2021
An aspergillosis diagnostic journey
February 5, 2021
Aspergillosis Monthly Patient & Carer Meeting
February 5, 2021
World Aspergillosis Day 2021
February 2, 2021
World Aspergillosis Day, 1 February 2021
January 28, 2021
COVID Vaccine for Aspergillosis Patients
December 11, 2020
COVID Precautions for the extremely vulnerable: Winter 2020
November 23, 2020
NHS: COVID-19. What if I’ve already got respiratory condition?
November 13, 2020
British Medical Journal Patient Leaflets
October 21, 2020
Vitamin D and COVID-19
October 16, 2020
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video